H

Hydra Biosciences

10 employees

Hydra Biosciences develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using ion channels.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Transient Receptor Potential (TRP) chemistry
Transient Receptor Potential (TRP) biology
Medical
Ion channel electrophysiology
Life Science

Date founded

2001

Funding rounds raised

Total raised

$34M

from 20 investors over 20 rounds

H

Hydra Biosciences raised $22M on January 16, 2009

Investors: Advanced Technology Ventures, Biogen Idec, Polaris Partners, Lilly Ventures, BioVentures Investors and Abingworth

H

Hydra Biosciences raised $34M on March 13, 2008

Investors: Advanced Technology Ventures, Polaris Partners, BioVentures Investors, Abingworth and Lilly Ventures

H

Hydra Biosciences raised $19M on January 12, 2004

Investors: Advanced Technology Ventures, ABBOTT, BioVentures Investors, Lilly Ventures, Polaris Partners and Abingworth

H

Hydra Biosciences raised $9.3M on July 26, 2002

Investors: Advanced Technology Ventures, Polaris Partners and Abingworth

FAQ